Dépendance et syndromes Parkinsoniens en gériatrie

Article Original / Original Article

Résumé

Les syndromes parkinsoniens (SP) sont d’autant plus fréquents et sources de dépendance que l’âge est élevé. Les modes d’entrée en dépendance sont nombreux et varient selon les étiologies. Si la Maladie de Parkinson reste le plus fréquent des SP, son incidence décroit avec l’âge à l’inverse de la Démence à corps de Lewy, des SP iatrogènes et vasculaires. La prise en charge de cette dépendance implique une approche multidisciplinaire, axée sur la prévention et la limitation de la iatrogénie, le choix de la dopathérapie, et les thérapeutiques non médicamenteuses comme la kinésithérapie.

Mots clés

Syndromes Parkinsoniens Dépendance Gériatrie Iatrogénie Maladie de Parkinson 

Références

  1. 1.
    Litvan, I., et al., Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord, 2003. 18(5): p. 467–486.PubMedCrossRefGoogle Scholar
  2. 2.
    de Rijk, M.C., et al., Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson’s disease. J Neurol Neurosurg Psychiatry, 1997. 62(1): p. 10–15.PubMedCrossRefGoogle Scholar
  3. 3.
    Benito-Leon, J., et al., Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology, 2004. 62(5): p. 734–741.PubMedGoogle Scholar
  4. 4.
    de Lau, L.M., et al., Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology, 2004. 63(7): p. 1240–1244.PubMedGoogle Scholar
  5. 5.
    Barbosa, M.T., et al., Parkinsonism and Parkinson’s disease in the elderly: a community-based survey in Brazil (the Bambui study). Mov Disord, 2006. 21(6): p. 800–808.PubMedCrossRefGoogle Scholar
  6. 6.
    Bennett, D.A., et al., Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med, 1996. 334(2): p. 71–76.PubMedCrossRefGoogle Scholar
  7. 7.
    Tison, F., et al., Prevalence of Parkinson’s disease in the elderly: a population study in Gironde, France. Acta Neurol Scand, 1994. 90(2): p. 111–115.PubMedCrossRefGoogle Scholar
  8. 8.
    Perez, F., et al., A 15-year population-based cohort study of the incidence of Parkinson’s disease and dementia with Lewy bodies in an elderly French cohort. J Neurol Neurosurg Psychiatry, 2010. 81(7): p. 742–746.PubMedCrossRefGoogle Scholar
  9. 9.
    Louis, E.D., et al., Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol, 2005. 62(2): p. 297–302.PubMedCrossRefGoogle Scholar
  10. 10.
    Richards, M., Y. Stern, and R. Mayeux, Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology, 1993. 43(11): p. 2184–2188.PubMedGoogle Scholar
  11. 11.
    Murray, A.M., et al., A longitudinal study of parkinsonism and disability in a community population of older people. J Gerontol A Biol Sci Med Sci, 2004. 59(8): p. 864–870.PubMedCrossRefGoogle Scholar
  12. 12.
    Wilson, R.S., et al., Progression of gait disorder and rigidity and risk of death in older persons. Neurology, 2002. 58(12): p. 1815–1819.PubMedGoogle Scholar
  13. 13.
    Chen, J.J., Parkinson’s disease: health-related quality of life, economic cost, and implications of early treatment. Am J Manag Care, 2010. 16 Suppl Implications: p. S87–S93.PubMedGoogle Scholar
  14. 14.
    Pressley, J.C., et al., The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology, 2003. 60(1): p. 87–93.PubMedGoogle Scholar
  15. 15.
    Richards, M., et al., Mild extrapyramidal signs and fun ctional impairment in ageing. Int J Geriatr Psychiatry, 2002. 17(2): p. 150–153.PubMedCrossRefGoogle Scholar
  16. 16.
    Louis, E.D., M.X. Tang, and R. Mayeux, Parkinsonian signs in older people in a community-based study: risk of incident dementia. Arch Neurol, 2004. 61(8): p. 1273–1276.PubMedCrossRefGoogle Scholar
  17. 17.
    Richards, M., Y. Stern, and R. Mayeux, Subtle extrapyramidal signs and incident dementia: a follow-up analysis. Neurology, 1995. 45(10): p. 1942.PubMedGoogle Scholar
  18. 18.
    Aarsland, D., et al., Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol, 2003. 60(3): p. 387–392.PubMedCrossRefGoogle Scholar
  19. 19.
    Wood, L.D., et al., Clinical review of treatment options for select nonmotor symptoms of Parkinson’s disease. Am J Geriatr Pharmacother, 2010. 8(4): p. 294–315.PubMedCrossRefGoogle Scholar
  20. 20.
    Rosenthal, E., et al., Association between cognition and function in patients with Parkinson disease with and without dementia. Mov Disord, 2010. 25(9): p. 1170–1176.PubMedCrossRefGoogle Scholar
  21. 21.
    Chaudhuri, K.R. and A.H. Schapira, Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol, 2009. 8(5): p. 464–474.PubMedCrossRefGoogle Scholar
  22. 22.
    Louis, E.D., et al., Progression of parkinsonian signs in Parkinson disease. Arch Neurol, 1999. 56(3): p. 334–337.PubMedCrossRefGoogle Scholar
  23. 23.
    Wickremaratchi, M.M., Y. Ben-Shlomo, and H.R. Morris, The effect of onset age on the clinical features of Parkinson’s disease. Eur J Neurol, 2009. 16(4): p. 450–456.PubMedCrossRefGoogle Scholar
  24. 24.
    Diederich, N.J., et al., Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Arch Neurol, 2003. 60(4): p. 529–533.PubMedCrossRefGoogle Scholar
  25. 25.
    Levy, G., et al.,Motor impairment in PD: relationship to incident dementia and age. Neurology, 2000. 55(4): p. 539–544.PubMedGoogle Scholar
  26. 26.
    Thanvi, B. and S. Treadwell, Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J, 2009. 85(1004): p. 322–326.PubMedCrossRefGoogle Scholar
  27. 27.
    Nguyen, N., et al., [Drug-induced parkinson syndromes]. Therapie, 2004. 59(1): p. 105–112.PubMedCrossRefGoogle Scholar
  28. 28.
    Avorn, J., et al., Neuroleptic drug exposure and treatment of parkinsonismin the elderly: a case-control study. Am J Med, 1995. 99(1): p. 48–54.PubMedCrossRefGoogle Scholar
  29. 29.
    Tison, F., et al., Parkinsonism and exposure to neuroleptic drugs in elderly people living in institutions. Clin Neuropharmacol, 1999. 22(1): p. 5–10.PubMedCrossRefGoogle Scholar
  30. 30.
    Champoux, N., et al., Use of neuroleptics: study of institutionalized elderly people in Montreal, Que. Can Fam Physician, 2005. 51: p. 696–697.PubMedGoogle Scholar
  31. 31.
    Christine, C.W. and M.J. Aminoff, Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance. Am J Med, 2004. 117(6): p. 412–419.PubMedCrossRefGoogle Scholar
  32. 32.
    Thanvi, B., N. Lo, and T. Robinson, Vascular parkinsonism—an important cause of parkinsonism in older people. Age Ageing, 2005. 34(2): p. 114–119.PubMedCrossRefGoogle Scholar
  33. 33.
    Kalra, S., D.G. Grosset, and H.T. Benamer, Differentiating vascular parkinsonism from idiopathic Parkinson’s disease: a systematic review. Mov Disord, 2010. 25(2): p. 149–156.PubMedCrossRefGoogle Scholar
  34. 34.
    McKeith, I.G., et al.,Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology, 2005. 65(12): p. 1863–1872.PubMedCrossRefGoogle Scholar
  35. 35.
    McKeith, I.G., et al., More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. Am J Geriatr Psychiatry, 2006. 14(7): p. 582–588.PubMedCrossRefGoogle Scholar
  36. 36.
    McKeith, I., et al., Dementia with Lewy bodies. Lancet Neurol, 2004. 3(1): p. 19–28.PubMedCrossRefGoogle Scholar
  37. 37.
    HAS, Maladie d’Alzheimer et autres démences.www.has-sante.fr, Guide médecin -Affection de longue durée, 2009.
  38. 38.
    Vokaer, M., N.A. Azar, and D.Z. de Beyl, Effects of levodopa on upper limb mobility and gait in Parkinson’s disease. J Neurol Neurosurg Psychiatry, 2003. 74(9): p. 1304–1307.PubMedCrossRefGoogle Scholar
  39. 39.
    Rainfray, M., et al., [Comprehensive geriatric assessment: a useful tool for prevention of acute situations in the elderly]. Ann Med Interne (Paris), 2002. 153(6): p. 397–402.Google Scholar

Copyright information

© Springer-Verlag France 2011

Authors and Affiliations

  1. 1.Pôle de Gérontologie CliniqueHôpital Xavier Arnozan, CHU de BordeauxPessac cedexFrance

Personalised recommendations